Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check6 days agoChange Detected- Consolidated site locations under a single 'Locations' header listing California, Maryland, New Jersey, and Ohio, removing the separate state-specific location subsections.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPublications section now notes that items are automatically filled from PubMed, and the revision tag has been updated to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the government funding/status notice from the page. The core study information, including the title, conditions, eligibility criteria, and study plan, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedNo substantive changes to the study details are visible between the two screenshots; the content appears unchanged.SummaryDifference0.2%

- Check84 days agoChange DetectedUpdated core content with an operating-status notice and a new version (v3.2.0); removed a previous term and older version marker (v3.1.0).SummaryDifference1%

- Check91 days agoChange DetectedExpanded immunology and biomarker terminology and updated cancer nomenclature and page version (from v3.0.2 to v3.1.0).SummaryDifference0.5%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.